BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7603192)

  • 1. Systemic thrombolysis for early intracoronary stent thrombosis.
    Fruhwald FM; Luha O; Eber B; Schumacher M; Zweiker R; Klein W
    Lancet; 1995 Jul; 346(8967):119-20. PubMed ID: 7603192
    [No Abstract]   [Full Text] [Related]  

  • 2. Tissue-type plasminogen activator: intracoronary applications.
    Tiefenbrunn AJ
    Cathet Cardiovasc Diagn; 1990 Feb; 19(2):108-15. PubMed ID: 2106393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with low-dose intracoronary recombinant tissue-type plasminogen activator for nonacute total occlusions before percutaneous transluminal coronary angioplasty.
    Ruocco NA; Currier JW; Jacobs AK; Ryan TJ; Faxon DP
    Am J Cardiol; 1991 Dec; 68(17):1609-13. PubMed ID: 1746461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of tissue plasminogen activator in the coronary care unit for acute closure after coronary angioplasty.
    Alzarka A; Haft JI; Goldstein JE
    Chest; 1990 May; 97(5):1241-2. PubMed ID: 2110053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of thrombotic occlusion of coronary stents to the indication for stenting, stent size, and anticoagulation.
    Rozenman Y; Lotan C; Mosseri M; Gotsman MS
    Am J Cardiol; 1995 Jan; 75(1):84-5. PubMed ID: 7801874
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of thrombolysis and thrombin in patients with acute coronary occlusion during percutaneous transluminal coronary angioplasty.
    Gulba DC; Daniel WG; Simon R; Jost S; Barthels M; Amende I; Rafflenbeul W; Lichtlen PR
    J Am Coll Cardiol; 1990 Sep; 16(3):563-8. PubMed ID: 2117619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with intracoronary tissue plasminogen activator: results of a multicenter registry. Intracoronary t-PA Registry Investigators.
    Cathet Cardiovasc Diagn; 1995 Mar; 34(3):196-201. PubMed ID: 7497484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful recanalization of an occluded coronary artery by percutaneous coronary intervention, systemic administration of tirofiban, a glycoprotein IIb/IIIa inhibitor, and intracoronary thrombolysis with alteplase.
    Meyners W; Peters S; Trümmel M; Koehler B
    Z Kardiol; 2004 May; 93(5):407-12. PubMed ID: 15160277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of a high bolus dose of tirofiban with half-dose thrombolytics for the treatment of subacute stent thrombosis.
    Di Pasquale P; Cannizzaro S; Paterna S
    Acta Cardiol; 2005 Feb; 60(1):61-3. PubMed ID: 15779855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombolytic retreatment with tissue plasminogen activator for threatened reinfarction and thrombotic coronary reocclusion.
    Becker RC
    Clin Cardiol; 1994 Jan; 17(1):3-13. PubMed ID: 8149679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of thrombotic complications after placement of the flexible coil stent.
    Agrawal SK; Ho DS; Liu MW; Iyer S; Hearn JA; Cannon AD; Macander PJ; Dean LS; Baxley WA; Roubin GS
    Am J Cardiol; 1994 Jun; 73(16):1216-9. PubMed ID: 8203343
    [No Abstract]   [Full Text] [Related]  

  • 12. [Early occlusion of the infarct-related artery after emergency PTCA for acute myocardial infarction].
    Shirotani M; Yui Y; Hattori R; Kawai C
    Jpn Circ J; 1992; 56 Suppl 5():1421-4. PubMed ID: 1291734
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety of adjunctive intracoronary thrombolytic therapy during complex percutaneous coronary intervention: initial experience with intracoronary tenecteplase.
    Kelly RV; Crouch E; Krumnacher H; Cohen MG; Stouffer GA
    Catheter Cardiovasc Interv; 2005 Nov; 66(3):327-32. PubMed ID: 16208711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary thrombolysis and myocardial salvage by tissue plasminogen activator.
    Thompson PL
    Lancet; 1988 Aug; 2(8609):519. PubMed ID: 2900452
    [No Abstract]   [Full Text] [Related]  

  • 15. Coronary thrombolysis and myocardial salvage by tissue plasminogen activator.
    Waugh NR
    Lancet; 1988 Mar; 1(8586):653. PubMed ID: 2894587
    [No Abstract]   [Full Text] [Related]  

  • 16. Coronary angioplasty and intracoronary thrombolysis are of limited efficacy in resolving early intracoronary stent thrombosis.
    Hasdai D; Garratt KN; Holmes DR; Berger PB; Schwartz RS; Bell MR
    J Am Coll Cardiol; 1996 Aug; 28(2):361-7. PubMed ID: 8800110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful revascularization by pulse infusion thrombolysis in a patient with Kawasaki disease combined with acute myocardial infarction.
    Inaba S; Higaki T; Nagashima M; Nishimura K; Ogimoto A; Higaki J; Okayama H
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1091-2. PubMed ID: 20965471
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparison of the clinical efficacy of recombinant tissue-type plasminogen activator thrombolysis with primary coronary stenting in acute myocardial infarction].
    Chen B; Wang W; Zhao H; Zhao M; Hubayi ; Xu CD; Lu M
    Zhonghua Nei Ke Za Zhi; 2002 Jan; 41(1):21-3. PubMed ID: 11940291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful revascularization of coronary artery occluded by massive intracoronary thrombi with alteplase and percutaneous coronary intervention.
    Kim JS; Kim JH; Jang HH; Lee YW; Song SG; Park JH; Chun KJ
    J Atheroscler Thromb; 2010 Jul; 17(7):768-70. PubMed ID: 20467185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful thrombolysis with intracoronary administration of tissue plasminogen activator in an infant with Kawasaki disease.
    Horigome H; Sekijima T; Miyamoto T
    Heart; 1997 Nov; 78(5):517-8. PubMed ID: 9415017
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.